Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125478231 | 12547823 | 1 | I | 20160418 | 0 | 20160711 | 20160711 | DIR | 62.00 | YR | M | N | 95.00000 | KG | 20160708 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125478231 | 12547823 | 1 | PS | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | Y | Y | 0 | 15 | IU | QD | ||||||
| 125478231 | 12547823 | 2 | C | METHADONE | METHADONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 3 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 4 | C | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 5 | C | ALBUTEROL INHALER | ALBUTEROL | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 6 | C | LYRICA | PREGABALIN | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 7 | C | XANAX | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 8 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 10 | C | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 11 | C | ASA | ASPIRIN | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 12 | C | APAP | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 13 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 14 | C | NOREPINEPHRINE | NOREPINEPHRINENOREPINEPHRINE BITARTRATE | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 15 | C | D5NS | 2 | 0 | |||||||||||||
| 125478231 | 12547823 | 16 | C | FAMOTIDINE. | FAMOTIDINE | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 17 | C | FENTANYL. | FENTANYL | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 18 | C | HEPARIN | HEPARIN SODIUM | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 19 | C | LACTOBACILLUS | LACTOBACILLUS ACIDOPHILUS | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 20 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 21 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 22 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 23 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 24 | C | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 25 | C | POTASSIUM | POTASSIUM | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 26 | C | PREGABALIN. | PREGABALIN | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 27 | C | PROPOFOL. | PROPOFOL | 1 | 0 | ||||||||||||
| 125478231 | 12547823 | 28 | C | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125478231 | 12547823 | 1 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125478231 | 12547823 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125478231 | 12547823 | Blood glucose increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 125478231 | 12547823 | HP |
Therapies reported
| no results found |